Citadel Advisors LLC Lowers Holdings in Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ)

Citadel Advisors LLC lowered its position in Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQFree Report) by 19.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,709 shares of the company’s stock after selling 2,574 shares during the quarter. Citadel Advisors LLC owned approximately 0.61% of Invesco Nasdaq Biotechnology ETF worth $230,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Raymond James Financial Inc. purchased a new position in Invesco Nasdaq Biotechnology ETF in the fourth quarter worth approximately $888,000. Strategic Financial Concepts LLC acquired a new stake in Invesco Nasdaq Biotechnology ETF during the fourth quarter worth approximately $1,699,000. Tower Research Capital LLC TRC raised its holdings in Invesco Nasdaq Biotechnology ETF by 148.5% during the fourth quarter. Tower Research Capital LLC TRC now owns 28,061 shares of the company’s stock worth $604,000 after purchasing an additional 16,768 shares in the last quarter. Finally, Advisory Services Network LLC raised its holdings in Invesco Nasdaq Biotechnology ETF by 5.8% during the fourth quarter. Advisory Services Network LLC now owns 53,609 shares of the company’s stock worth $1,154,000 after purchasing an additional 2,922 shares in the last quarter.

Invesco Nasdaq Biotechnology ETF Trading Up 1.6%

IBBQ stock opened at $21.25 on Friday. Invesco Nasdaq Biotechnology ETF has a twelve month low of $17.84 and a twelve month high of $24.84. The company’s 50 day moving average is $20.24 and its two-hundred day moving average is $21.56. The stock has a market cap of $38.46 million, a P/E ratio of 23.20 and a beta of 0.61.

Invesco Nasdaq Biotechnology ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, March 28th. Shareholders of record on Monday, March 24th were issued a dividend of $0.0402 per share. The ex-dividend date of this dividend was Monday, March 24th.

Invesco Nasdaq Biotechnology ETF Company Profile

(Free Report)

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.

Read More

Institutional Ownership by Quarter for Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ)

Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.